Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet Lond Engl 12 Februar. 2022;399(10325):629–55.

Article  Google Scholar 

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS. u. a. attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis Januar. 2019;19(1):56–66.

Article  Google Scholar 

Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in Intensive Care Units (SARI). Dtsch Arzteblatt Int 15 Dezember. 2017;114(50):858–65.

Google Scholar 

Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Döbele S. u. a. effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis September. 2017;17(9):990–1001.

Article  Google Scholar 

Kallen MC, Binda F, Ten Oever J, Tebano G, Pulcini C, Murri R. u. a. comparison of antimicrobial stewardship programmes in acute-care hospitals in four European countries: a cross-sectional survey. Int J Antimicrob Agents September. 2019;54(3):338–45.

Article  CAS  Google Scholar 

Mo Y, Oonsivilai M, Lim C, Niehus R, Cooper BS. Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: a modelling study and meta-analysis. PLoS Med Juni. 2023;20(6):e1004013.

Article  CAS  Google Scholar 

Plachouras D, Kärki T, Hansen S, Hopkins S, Lyytikäinen O, Moro ML. November, Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. 2018;23(46):1800393.

Aghdassi SJS, Gastmeier P, Piening BC, Behnke M, Peña Diaz LA, Gropmann A. u. a. antimicrobial usage in German acute care hospitals: results of the third national point prevalence survey and comparison with previous national point prevalence surveys. J Antimicrob Chemother 1 April. 2018;73(4):1077–83.

Article  CAS  Google Scholar 

Aghdassi SJS, Hansen S, Peña Diaz LA, Gropmann A, Saydan S, Geffers C. Healthcare-Associated infections and the Use of antibiotics in German hospitals—results of the Point Prevalence Survey of 2022 and comparison with earlier findings. Dtsch Arzteblatt Int. 3. Mai 2024;(Forthcoming):arztebl.m2024.0033.

Adekoya I, Maraj D, Steiner L, Yaphe H, Moja L, Magrini N. u. a. comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study. Lancet Infect Dis Oktober. 2021;21(10):1429–40.

Article  CAS  Google Scholar 

Munting A, Regina J, Damas J, Lhopitallier L, Kritikos A, Guery B. u. a. impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis April. 2022;28(4):558–63.

CAS  Google Scholar 

de With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T. u. a. strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious diseases. Infect Juni. 2016;44(3):395–439.

Google Scholar 

Deshpande A, Richter SS, Haessler S, Lindenauer PK, Yu PC, Zilberberg MD. u. a. de-escalation of empiric antibiotics following negative cultures in hospitalized patients with pneumonia: Rates and outcomes. Clin Infect Dis off Publ Infect Dis Soc Am 26 April. 2021;72(8):1314–22.

Article  Google Scholar 

Moehring RW, Yarrington ME, Warren BG, Lokhnygina Y, Atkinson E, Bankston A. u. a. evaluation of an opt-out protocol for antibiotic de-escalation in patients with suspected Sepsis: a Multicenter, Randomized, Controlled Trial. Clin Infect Dis off Publ Infect Dis Soc Am 8 Februar. 2023;76(3):433–42.

Article  Google Scholar 

Waagsbø B, Tranung M, Damås JK, Heggelund L. Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study. BMC Pulm Med 14 Oktober. 2022;22(1):379.

Article  Google Scholar 

Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K. u. a. diagnosis and treatment of adults with community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 1 Oktober. 2019;200(7):e45–67.

Article  Google Scholar 

Ewig S, Kolditz M, Pletz M, Altiner A, Albrich W et al. Drömann D, [Management of Adult Community-Acquired Pneumonia and Prevention - Update 2021 - Guideline of the German Respiratory Society (DGP), the Paul-Ehrlich-Society for Chemotherapy (PEG), the German Society for Infectious Diseases (DGI), the German Society of Medical Intensive Care and Emergency Medicine (DGIIN), the German Viological Society (DGV), the Competence Network CAPNETZ, the German College of General Practitioneers and Family Physicians (DEGAM), the German Society for Geriatric Medicine (DGG), the German Palliative Society (DGP), the Austrian Society of Pneumology Society (ÖGP), the Austrian Society for Infectious and Tropical Diseases (ÖGIT), the Swiss Respiratory Society (SGP) and the Swiss Society for Infectious Diseases Society (SSI)]. Pneumol Stuttg Ger. September 2021;75(9):665–729.

Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E. u. a. Pseudomonas aeruginosa Bloodstream infections presenting with septic shock in Neutropenic Cancer patients: impact of empirical antibiotic therapy. Microorganisms 30 März. 2024;12(4):705.

Article  CAS  Google Scholar 

Gudiol C, Albasanz-Puig A, Laporte-Amargós J, Pallarès N, Mussetti A, Ruiz-Camps. I, u. a. clinical predictive model of Multidrug Resistance in Neutropenic Cancer patients with bloodstream infection due to Pseudomonas aeruginosa. Antimicrob Agents Chemother 24 März. 2020;64(4):e02494–19.

CAS  Google Scholar 

Hyun H, Song JY, Yoon JG, Seong H, Noh JY, Cheong HJ. u. a. risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: microbiological distribution, antibiotic resistance, and clinical outcomes. PLoS ONE. 2022;17(6):e0270261.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rojas A, Palacios-Baena ZR, López-Cortés LE, Rodríguez-Baño J. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis August. 2019;25(8):964–70.

CAS  Google Scholar 

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O. u. a. Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J August. 2018;52(2):1701190.

Article  Google Scholar 

Fujitani S, Sun HY, Yu VL, Weingarten JA. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest April. 2011;139(4):909–19.

Article  Google Scholar 

Stapleton PJ, Izydorcyzk C, Clark S, Blanchard A, Wang PW, Yau Y. u. a. Pseudomonas aeruginosa strain-sharing in early infection among children with cystic fibrosis. Clin Infect Dis off Publ Infect Dis Soc Am 2 November. 2021;73(9):e2521–8.

Article  CAS  Google Scholar 

Herrera S, Bodro M, Soriano A. Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections. Curr Opin Infect Dis 1 Dezember. 2021;34(6):686–92.

Article  CAS  Google Scholar 

Fernández-Barat L, Ferrer M, De Rosa F, Gabarrús A, Esperatti M, Terraneo S. u. a. intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. J Infect Februar. 2017;74(2):142–52.

Article  Google Scholar 

Cobos-Trigueros N, Solé M, Castro P, Torres JL, Hernández C, Rinaudo M. u. a. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care Lond Engl 4 Mai. 2015;19(1):218.

Article  Google Scholar 

Kresken M, Wohlfarth E, Wichelhaus TA, Gatermann SG, Pfennigwerth N, Eisfeld J. u. a. susceptibility of Multidrug-Resistant Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa from Germany to Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Imipenem-Relebactam. Microb Drug Resist Larchmt N April. 2023;29(4):138–44.

Article  CAS  Google Scholar